Valuation: Merck KGaA

Market Cap 56.46B 64.75B 53.17B 48.42B 90.79B 6,203B 90.9B 637B 245B 3,160B 243B 238B 10,197B P/E 2026 *
22x
P/E 2027 * 19.3x
Enterprise Value 64.21B 73.64B 60.47B 55.07B 103B 7,055B 103B 724B 279B 3,594B 277B 270B 11,597B EV / Sales 2026 *
2.99x
EV / Sales 2027 * 2.75x
Free-Float
29.73%
Yield 2026 *
1.81%
Yield 2027 * 1.85%
1 day+3.12%
1 week+1.57%
Current month-4.41%
1 month-3.68%
3 months-0.49%
6 months+29.34%
Current year+8.45%
1 week 129.05
Extreme 129.05
132.3
1 month 129.05
Extreme 129.05
142.35
Current year 100.65
Extreme 100.65
147.95
1 year 100.65
Extreme 100.65
147.95
3 years 100.65
Extreme 100.65
176.5
5 years 100.65
Extreme 100.65
231.3
10 years 74.56
Extreme 74.56
231.3
Manager TitleAgeSince
Chief Executive Officer 61 01/05/2026
Director of Finance/CFO 56 01/07/2023
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 62 26/04/2019
Director/Board Member 60 09/05/2014
Director/Board Member 49 28/05/2020
Change 5-day change 1-year change 3-year change Capi.($)
+3.12%+1.57% - - 64.74B
+2.28%+3.67%+86.77%+40.69% 362B
+2.12%+1.57%+21.37%-17.38% 64.74B
-0.04%+3.96%+43.34%+181.16% 12.76B
-0.29%+2.94%-4.00%-15.43% 7.53B
-0.13%-2.27%-31.63%-12.22% 4.38B
-0.40%-4.79%-36.26%+6.12% 4.08B
+4.64%+8.45%-26.33%-9.09% 2.96B
+1.26%+2.27%-9.68%+53.56% 2.44B
+2.77%+3.95%-21.46%-32.27% 1.93B
Average +1.54%+1.55%+2.46%+21.68% 51.46B
Weighted average by Cap. +2.28%+1.62%+71.07%+34.17%

Financials

2026 *2027 *
Net sales 21.48B 24.63B 20.23B 18.42B 34.54B 2,360B 34.58B 242B 93.37B 1,202B 92.53B 90.48B 3,879B 22.64B 25.97B 21.33B 19.42B 36.42B 2,488B 36.46B 255B 98.44B 1,267B 97.56B 95.4B 4,090B
Net income 2.55B 2.93B 2.41B 2.19B 4.11B 281B 4.11B 28.81B 11.1B 143B 11B 10.76B 461B 2.85B 3.27B 2.68B 2.44B 4.58B 313B 4.59B 32.14B 12.39B 160B 12.28B 12.01B 515B
Net Debt 7.75B 8.89B 7.3B 6.65B 12.46B 852B 12.48B 87.43B 33.7B 434B 33.39B 32.65B 1,400B 5.83B 6.68B 5.49B 5B 9.37B 640B 9.38B 65.74B 25.34B 326B 25.11B 24.55B 1,053B
Logo Merck KGaA
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (42.6%); - pharmaceutical products (40.8%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (16.6%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Switzerland (1.9%), Europe (23.7%), the United States (24.8%), North America (1.3%), China (13.7%), Asia/Pacific (19.2%), Latin America (6.9%), Middle East and Africa (3.7%).
Employees
62,136
Date Price Change Volume
21/09/26 132.25 +2.48% 1,116
18/09/26 €129.05 -1.22% 40
17/09/26 €130.65 -0.31% 160
16/09/26 €131.05 +0.50% 0
15/09/26 €130.40 +0.15% 19
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
129.85EUR
Average target price
154.21EUR
Spread / Average Target
+18.76%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!